As previously discussed on this blog, on July 16 the American Society of Clinical Oncology (ASCO) issued a provisional clinical opinion or PCO on the merits of screening for prostate cancer (see prior commentary on this PCO).
ASCO has now, in addition, released two associated items specifically designed to assist individual patients to make appropriate decisions about whether they do or do not want to get PSA tests:
- A patient-specific brochure entitled “Prostate-specific antigen (PSA) testing for prostate cancer screening” and
- A patient decision aid – ”Decision aid tool: Prostate cancer screening with PSA testing“
It seems likely that not everyone is going to agree with the content of these two documents because a lot depends on personal interpretation of the data on which these two documents are based. However, The “New” Prostate Cancer InfoLink believes that these will be helpful materials for those patients who want to be able to make good decisions about the value of PSA testing for themselves as individuals (as opposed to letting others make decisions for them).